The effect of a self-management lymphedema education program on lymphedema, lymphedema-related symptoms, patient compliance, daily living activities and patient activation in patients with breast cancer-related lymphedema: A quasi-experimental study

Cansız G., Arıkan Dönmez A., Kapucu S., Borman P.

European Journal of Oncology Nursing, cilt.56, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 56
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1016/j.ejon.2021.102081
  • Dergi Adı: European Journal of Oncology Nursing
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus, ASSIA, CINAHL, EMBASE, MEDLINE, Psycinfo
  • Anahtar Kelimeler: Breast cancer, Lymphedema, Lymphedema management, Patient education, Self-management, DECONGESTIVE THERAPY, MEASURE PAM, ADHERENCE, WOMEN, CARE, RISK, BIOIMPEDANCE, RELIABILITY, ADAPTATION, BEHAVIORS
  • Hacettepe Üniversitesi Adresli: Evet

Özet

© 2021Purpose: This study was undertaken to determine the effects of self-management lymphedema education program (SMLEP) on lymphedema, lymphedema-related symptoms, patient compliance, activities of daily living (ADL) and patient activation in patients with breast cancer-related lymphedema (BCRL). Methods: A quasi-experimental design without a control group was used to conduct this study in a lymphedema center of a university hospital in Ankara. A total of 44 patients with BCRL participated in the study. Patients (n = 44) received a SMLEP in the form of face-to-face sessions and information booklet at the beginning of the study. Patients were evaluated for upper extremity (UE) volume, and they were followed for 12 months. UE volume, symptom severity, physical function, patient compliance, ADL and patient activity level were measured at the beginning and end of the study. Results: A significant reduction was found in the UE volume (P = 0.000; ES = −0.79) and swelling and numbness symptom scores (P = 0.016; ES = - 0.26; P = 0.002; ES = −0.45, respectively). In addition, a significant increase was found in patient compliance (P = 0.001; ES = −0.29), ADL (P = 0.018; ES = −0.16) and patient activity level (P = 0.000; ES = −0.39) compared to those at the baseline. Conclusion: The present study results showed that SMLEP reduced UE volume and lymphedema-related symptoms. In addition, results demonstrated its effectiveness on patient compliance and activity level, and independent performance of ADL. The results suggest that SMLEP is an effective approach in long-term lymphedema self-management.